Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

A woman with severe hair loss was successfully treated with the drug adalimumab.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Dutasteride effectively and safely treats male hair loss for over a year.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

CL22209, an Asparagus racemosus extract, safely reduces perimenopausal symptoms and balances hormones.

Low-dose dutasteride effectively and safely promotes hair growth in men with androgenetic alopecia.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Thorough evaluation and surgery are crucial for managing rare ovarian tumors in postmenopausal women with high androgen levels.

Both treatments are similarly effective, but paclitaxel-carboplatin is cheaper and has more severe side effects.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Antiandrogens don't help with COVID-19 and aren't recommended.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

RF-mesotherapy with dutasteride may be a promising alternative treatment for hair loss.

A postmenopausal woman had high testosterone from her right adrenal gland, leading to recommended surgery.

Most patients experienced significant but reversible hair loss during treatment.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Dutasteride mesotherapy for hair loss can cause lasting bald patches.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Promising cancer treatments were found, but the manufacturer closed.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.